ArticleJournal of medical case reports2025
Sinonasal mucosal melanoma in an elderly patient: a case report.
Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMucosal melanoma is an aggressive Malignancy arising from melanocytes in mucosal membranes. Sinonasal mucosal melanoma accounts for approximately 1% of all melanomas and 4% of all sinonasal tumors. Unlike cutaneous melanoma, its etiology remains unclear, and it is often diagnosed at an advanced stage owing to nonspecific symptoms, leading to poor prognosis. CASE PRESENTATION: We present the case of an 80-year-old African female with nasal obstruction and recurrent epistaxis for 6 months. Clinical examination and imaging revealed an enhancing soft tissue sinonasal lesion with osseous destruction. Functional endoscopic sinus surgery was performed for tumor debulking, and histopathological analysis confirmed mucosal melanoma with immunohistochemical positivity for HMB45. Despite surgical intervention, the patient was placed on home care owing to the aggressive nature of the disease and limited treatment options. Imaging confirmed local invasion but no distant metastases.
conclusionSinonasal mucosal melanoma is an aggressive entity requiring early diagnosis and multimodal management. Surgical resection remains the primary treatment, but novel therapeutic strategies, including immune checkpoint inhibitors, are needed to improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.